Download Citation
Article Source:
Preclinical safety assessment of modified gamma globin lentiviral vector-mediated autologous hematopoietic stem cell gene therapy for hemoglobinopathies
Shadid M,
Shrestha A,
Malik P
(2024)
Preclinical safety assessment of modified gamma globin lentiviral vector-mediated autologous hematopoietic stem cell gene therapy for hemoglobinopathies.
PLOS ONE 19(7): e0306719.
https://doi.org/10.1371/journal.pone.0306719